Distributional cost-effectiveness analysis

Today, Distributional cost-effectiveness analysis is a topic that arouses great interest and debate in society. From its origins to the present, Distributional cost-effectiveness analysis has been the subject of study and analysis by experts from different disciplines. Its impact on people's lives and on the development of humanity has been profound, and its relevance has remained over time. In this article, we will explore in detail the most relevant aspects of Distributional cost-effectiveness analysis, from its origins to its implications today. From his impact on society to his influence on popular culture, Distributional cost-effectiveness analysis has left an indelible mark on history and on people's minds.

Distributional cost-effectiveness analysis (DCEA) is an extension of cost-effectiveness analysis (CEA) that incorporates concern for both the average levels of outcomes as well as the distribution of outcomes. It is particularly useful when evaluating interventions to tackle health inequality.[1][2]

DCEA includes Extended Cost Effectiveness Analysis, which in addition to standard CEA assesses the costs and effectiveness for different socioeconomic groups.[3]

References

  1. ^ Asaria, M; Griffin, S; Cookson, R; Whyte, S; Tappenden, P (June 2015). "Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme" (PDF). Health Economics. 24 (6): 742–54. doi:10.1002/hec.3058. PMID 24798212.
  2. ^ Asaria, M; Griffin, S; Cookson, R (January 2016). "Distributional Cost-Effectiveness Analysis: A Tutorial". Medical Decision Making. 36 (1): 8–19. doi:10.1177/0272989x15583266. PMC 4853814. PMID 25908564.
  3. ^ Verguet, Stéphane; Kim, Jane J.; Jamison, Dean T. (2016). "Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial". Pharmacoeconomics. 34 (9): 913–923. doi:10.1007/s40273-016-0414-z. ISSN 1170-7690. PMC 4980400. PMID 27374172.